Affiliation:
1. The Affiliated Hospital of Inner Mongolia national University
2. People's Hospital of Liaoning Province
3. Affiliated hospital of Inner mongolia national university
4. The first affiliated hospital of China medical university
Abstract
Abstract
Background
Previous observational studies have highlighted potential relationships between the telomerase reverse transcriptase (TERT) gene, short leukocyte telomere length (LTL), and cerebrovascular disease. However, it remains to be established as to whether TERT gene variants are associated with an elevated risk of cerebral small vessel disease (CSVD), and whether there is a causal relationship between LTL and CSVD.
Methods
Five TERT single nucleotide polymorphisms (SNPs) were analyzed in 307 CSVD patients and 320 healthy controls in whom LTL values were quantified. Allele models and four genetic models were used to explore the relationship between these SNP genotypes and CSVD risk. A Mendelian randomization analysis of CSVD risk was then performed using LTL-related SNPs and the polygenic risk score (PRS) constructed from these SNPs as genetic instrumental variables to predict the causal relationship between LTL and CSVD risk.
Results
Model association analyses identified two SNPs that were significantly associated with CSVD risk. LTL was significantly correlated with age (P < 0.001), and the MR analysis revealed an association between short LTL and an elevated risk of CSVD. PRS-based genetic prediction of short LTLs was also significantly related to an elevated CSVD risk.
Conclusion
Multiple genetic models and MR results indicate that TERT gene SNPs may be related to an elevated risk of CSVD, and that shorter LTL may be causally linked to such CSVD risk.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Litak J, Mazurek M, Kulesza B et al. Cereb Small Vessel Disease Int J Mol Sci 2020;21.
2. CNS small vessel disease: A clinical review;Cannistraro R;Neurology,2019
3. Hereditary cerebral small vessel disease and stroke;Søndergaard C;Clin Neurol Neurosurg,2017
4. Telomeres and telomerase: three decades of progress;Shay J;Nat Rev Genet,2019
5. Telomerase and Ageing;Saretzki G;Subcell Biochem,2018